However, the downregulation of cGMP by 6-OHDA may account for the increase in PDE1B expression [103,104], whereas the increase in cAMP could be due to the downregulation of PDE10A expression [103], which also occurs in PD patients [96]. The gene discussed is PDE10A; the disease is Parkinson disease.